![](/img/cover-not-exists.png)
Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis*
Sheng Duh, Mei, Dial, Ellison, Choueiri, Toni K., Fournier, Andree-Anne, Antras, Lucia, Rodermund, Douglas, Neary, Maureen P., Oh, William K.Volume:
25
Language:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1185/03007990903084800
Date:
August, 2009
File:
PDF, 426 KB
english, 2009